Clinical trial
Paracetamol Oral Paediatric Suspension at 4.8%: Study of Acceptability and…
NCT00434681 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00434681 |
|---|---|
| Title | Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety. |
| Official title | Multicentre, Open, Non-Comparative Study of the Acceptability and Safety of Paracetamol Oral Paediatric Suspension at 4.8%. |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fever, Pain |
| Intervention type | Drug |
| Interventions | paracetamol 4.8% paediatric oral suspension |
| Enrollment | 48 |
| Start date | Oct 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Feb 13, 2007 |
| Last update posted | Jul 21, 2008 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: